DBV Technologies S.A (DBVT)

Etorro trading 970x250
DBV Technologies S.A (DBVT) Logo

About DBV Technologies S.A

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents, and adults. The company is also developing Viaskin Milk that is in Phase I/II clinical trial for the treatment of Immunoglobulin E (IgE) mediated cow’s milk protein allergy (CMPA) and milk-induced eosinophilic esophagitis; Viaskin Egg, a pre-clinical stage product for the treatment of hen’s egg allergy; and booster vaccine for Bordetella pertussis. Its other earlier stage research programs include a vaccine for the respiratory syncytial virus, as well as treatments for Crohn’s disease, celiac disease, and type I diabetes. The company has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was founded in 2002 and is headquartered in Montrouge, France. Address: 177-181 Avenue Pierre Brossolette, Montrouge, France, 92120

DBV Technologies S.A News and around…

Latest news about DBV Technologies S.A (DBVT) common stock and company :

2 Biotechs That Recently Soared -- Are They Buys?
30 Jun, 2022 FinancialContent

Let's consider the risk-reward profile of these companies before jumping on the bandwagon.

DBV Technologies to Participate in Upcoming EAACI 2022 Congress
28 Jun, 2022 Yahoo! Finance

Montrouge, France, June 28, 2022 DBV Technologies to Participate in Upcoming EAACI 2022 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the hybrid in-person and virtual European Academy of Allergy and Clinical Immunology (EAACI) Annual Scientific meeting, July 1 – 3, 2022, in Prague, Czech Republic. Two scientific presentations have been accepted, including one non-cl

DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York
16 Jun, 2022 Yahoo! Finance

Montrouge, France, June 16, 2022 DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, and Dr. Pharis Mohideen, Chief Medical Officer, will participate in a fireside chat on Thursday, June 16, 2022, at 12:00 p.m. ET at the JMP Securities Life Sciences Conference in New York. A we

41 Stocks Moving In Tuesday's Mid-Day Session
14 Jun, 2022 FinancialContent

Gainers Revlon, Inc. (NYSE: REV) rose 125.5% to $2.6499. Revlon’s stock dropped sharply on Monday after the company is ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
14 Jun, 2022 FinancialContent

Gainers Clovis Oncology (NASDAQ:CLVS) stock increased by 32.8% to $0.93 during Tuesday's pre-market session. The ...

20 Stocks Moving in Tuesday's Pre-Market Session
14 Jun, 2022 FinancialContent

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 48.5% to $2.57 in pre-market trading after the company reached ...

93 Biggest Movers From Yesterday
14 Jun, 2022 FinancialContent

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company ...

70 Stocks Moving In Monday's Mid-Day Session
13 Jun, 2022 FinancialContent

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data ...

12 Health Care Stocks Moving In Monday's Pre-Market Session
13 Jun, 2022 FinancialContent

Gainers Day One Biopharmaceutical (NASDAQ:DAWN) stock moved upwards by 82.8% to $12.1 during Monday's pre-market ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
13 Jun, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We're starting off the week with a dive into the biggest pre-market stock movers for Monday morning! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

30 Stocks Moving in Monday's Pre-Market Session
13 Jun, 2022 FinancialContent

Gainers G Medical Innovations Holdings Ltd (NASDAQ: GMVD) rose 53.6% to $0.5301 in pre-market trading after dropping more than 28% ...

91 Biggest Movers From Friday
13 Jun, 2022 FinancialContent

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced ...

44 Stocks Moving In Friday's Mid-Day Session
10 Jun, 2022 FinancialContent

Gainers Cogent Biosciences, Inc. (NASDAQ: COGT) shares jumped 77% to $8.79 after the company reported initial data from its ...

12 Health Care Stocks Moving In Friday's Pre-Market Session
10 Jun, 2022 FinancialContent

Gainers Alaunos Therapeutics (NASDAQ:TCRT) shares increased by 31.2% to $1.12 during Friday's pre-market session. ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
10 Jun, 2022 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investors! With another day starting comes another breakdown of the biggest pre-market stock movers for Friday! The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS It doesn’t matter if you have $500 in savings or $5 million. Do this now. Get in Now on Tiny $3 ‘Forever Battery’ Stock Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”

25 Stocks Moving in Friday's Pre-Market Session
10 Jun, 2022 FinancialContent

Gainers Regis Corporation (NYSE: RGS) rose 74.4% to $0.9753 in pre-market trading. Regis partnered with salon technology provider ...

69 Biggest Movers From Yesterday
10 Jun, 2022 FinancialContent

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares climbed 189.9% to close at $1.12 on Thursday. NextPlay ...

Why DBV Technologies Stock Popped Again Today
09 Jun, 2022 FinancialContent

The French biotech kept its upward momentum going with news of nearly $200 million in fresh funding.

12 Health Care Stocks Moving In Thursday's Intraday Session
09 Jun, 2022 FinancialContent

Gainers Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares rose 41.2% to $1.35 during Thursday's regular session. Zynerba ...

36 Stocks Moving In Thursday's Mid-Day Session
09 Jun, 2022 FinancialContent

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) jumped 65% to $0.6382. Applied UV, Inc. (NASDAQ: AUVI) gained 63.8% to ...

83 Biggest Movers From Yesterday
09 Jun, 2022 FinancialContent

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of ...

DBV Technologies Announces Private Placement Financing of $194 Million
09 Jun, 2022 Yahoo! Finance

Montrouge, France, June 9, 2022 DBV Technologies Announces Private Placement Financing of $194 Million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Global Select Market: DBVT), a clinical-stage biopharmaceutical company, today announced an aggregate $194 million private investment in public equity (PIPE) financing (corresponding to €181 million on the basis of an exchange rate of $1.0739 = €1.00 published by the European Central Bank on June 8, 2022) from the sale of 32,855,669

Why DBV Technologies Was a Big Winner on Wednesday
08 Jun, 2022 FinancialContent

Its peanut allergy patch tests quite well in very young patients.

HC Wainwright Says Viaskin Benefit Affirmed In Toddlers...What's Next?
08 Jun, 2022 FinancialContent

HC Wainwrightbelieves the most significant takeaway fromDBV Technologies SA's(NASDAQ: DBVT)trial ...

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
08 Jun, 2022 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA Advisors Back ...

DBV Technologies Shares Jump On Positive Data From Peanut Allergy Trial In Toddlers
08 Jun, 2022 FinancialContent

DBV Technologies SA's(NASDAQ: DBVT) pivotal Phase 3 EPITOPE trial of Viaskin Peanut 250 g for peanut-allergic ...

DBV Technologies' Shares Shoot Higher As Positive Results From Late-Stage Study Of Peanut Allergy In Toddlers Met Primary Endpoint
07 Jun, 2022 FinancialContent

DBV Technologies (NASDAQ: DBVT) announced positive topline results from EPITOPE study of its drug candidate Viaskin Peanut 250 g ...

12 Health Care Stocks Moving In Tuesday's After-Market Session
07 Jun, 2022 FinancialContent

Gainers DBV Technologies (NASDAQ:DBVT) shares moved upwards by 38.6% to $2.12 during Tuesday's after-market session. This security ...

DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers
07 Jun, 2022 Yahoo! Finance

Montrouge, France, June 7, 2022 DBV Technologies Announces Positive Topline Results from Phase 3 EPITOPE Trial of Viaskin Peanut in Peanut-Allergic Toddlers 67.0% of subjects treated with Viaskin Peanut 250 µg met response criteria at 12 months, compared with 33.5% of subjects in the placebo armPivotal trial met primary endpoint: lower bound of the 95% confidence interval (CI) of the difference between treatment arms was 22.4%, exceeding the pre-specified threshold of 15%Safety results were gene

Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022
17 May, 2022 Yahoo! Finance

Monthly information regarding the total number of voting rights and total number of shares of the Company as of April 30, 2022 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers) Market : NYSE Euronext Paris ISIN Code: FR 0010417345 Date Total number of shares Total number of voting rights04/30/202255,095,537 Total gross of voting rights: 55,095,537 Total net* of voting rights: 54,920,329 * Total net = total number of voting rights attached to shares – shares witho

DBV Technologies S.A (DBVT) is a NASDAQ Common Stock listed in , ,

970x250